Incyte INCY Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 371.1%-0.2pp | 371.2%+0.1pp | 371.1%+0.1pp | 371%-0.2pp | 371.2%-0.5pp | |
| Operating margin | 116.1%+26.1pp | 90%+28.0pp | 62%+32.1pp | 29.9%+25.4pp | 4.5%-14.3pp | |
| Net margin | 95.4%+26.2pp | 69.2%+24.3pp | 44.9%+23.9pp | 21%+16.5pp | 4.6%-19.3pp | |
| EBITDA margin | 123.5%+25.8pp | 97.7%+27.7pp | 70%+31.8pp | 38.2%+25.1pp | 13.1%-14.5pp | |
| Free cash flow margin | 103.3%+19.7pp | 83.6%+19.6pp | 64.1%+23.6pp | 40.4%+23.4pp | 17.1%-13.2pp | |
| Returns | ||||||
| Return on equity | 115.4%+30.4pp | 85%+29.1pp | 55.9%+29.6pp | 26.3%+21.8pp | 4.5%-14.7pp | |
| Return on assets | 80.2%+21.5pp | 58.7%+20.2pp | 38.4%+20.4pp | 18%+14.8pp | 3.2%-11.2pp | |
| Return on invested capital | 216.3%+61.0pp | 155.3%+57.7pp | 97.6%+55.0pp | 42.6%+37.5pp | 5.1%-22.2pp | |
| Efficiency | ||||||
| Asset turnover | 3.4×+0.1× | 3.2×+0.1× | 3.1×+0.1× | 3×+0.2× | 2.8×+0.1× | |
| Inventory turnover | 4.3×+0.1× | 4.2×0.0× | 4.2×-0.3× | 4.5×-0.3× | 4.8×-0.3× | |
| Liquidity | ||||||
| Current ratio | 13×+1.6× | 11.4×+1.3× | 10.1×+1.3× | 8.7×+0.9× | 7.8×-1.4× | |
| Quick ratio | 12×+1.6× | 10.4×+1.3× | 9.1×+1.2× | 7.8×+0.8× | 7×-1.5× | |
| Cash ratio | 7.7×+1.2× | 6.5×+1.0× | 5.5×+1.0× | 4.6×+0.8× | 3.8×-1.3× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -6.9×+5.2× | -12.1×+8.9× | -21×+34.3× | -55.3×+7.7× | -63.1×-2.9× | |
| Interest coverage | 2,450.3×+620× | 1,830.6×+597× | 1,233.6×+673× | 560.1×+477× | 82.9×-204× | |
| Per Share | ||||||
| Book value per share | $97.01+9.8% | $88.33+11.9% | $78.96+9.6% | $72.06+11.2% | $64.81-7.5% | |
| Valuation | ||||||
| Market capitalization | $68.04B+11.5% | $61.03B+11.1% | $54.94B+4.1% | $52.8B-0.5% | $53.05B-2.0% | |
| Enterprise value | $57.25B+10.6% | $51.76B+9.9% | $47.09B+2.2% | $46.1B-2.6% | $47.31B+0.7% | |
| Price / earnings | 57.4×-538× | 595.3×-393× | 988.2×-430× | 1,418.2×-125× | 1,542.7×+534× | |
| Price / sales | 13.6×+0.8× | 12.8×+0.6× | 12.1×-0.1× | 12.2×-0.6× | 12.9×-0.7× | |
| Price / book | 13.8×+0.1× | 13.7×-0.1× | 13.8×-1.0× | 14.8×-1.3× | 16.1×+0.8× | |
| EV / EBITDA | 37.1×-28.2× | 65.3×-67.4× | 132.7×-363× | 495.2×-114× | 609.2×+24.9× | |
| EV / sales | 11.5×+0.6× | 10.8×+0.4× | 10.4×-0.3× | 10.7×-0.8× | 11.5×-0.3× | |
| Free cash flow yield | 30.3%+4.9pp | 25.5%+4.8pp | 20.7%+6.9pp | 13.8%+7.9pp | 5.9%-3.2pp | |
| Earnings yield | 28%+7.5pp | 20.5%+6.4pp | 14.1%+7.0pp | 7.2%+5.8pp | 1.4%-5.6pp | |
| PEG ratio | 0×— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Incyte's profit margins?
- Incyte (INCY) runs a 92.5% gross margin and a 30.0% operating margin, with a 26.7% net margin.
- Where do Incyte's ratios come from?
- Every ratio is computed from Incyte's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
